BenzingaOctober 22, 2026 at 2:04 AM NY5 Days Ago
BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $125
BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $134 to $125.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
